[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100600261":3},{"organization":4,"armGroups":7,"interventions":26,"overallOfficials":31,"centralContacts":35,"locations":45,"responsibleParty":198,"collaborators":201,"id":242,"slug":243,"hasResults":244,"nctId":245,"briefTitle":246,"officialTitle":247,"acronym":248,"eligibilityCriteria":249,"healthyVolunteers":244,"sex":250,"minAge":251,"maxAge":10,"enrollmentInfo":252,"targetDuration":255,"studyType":256,"phases":10,"briefSummary":257,"conditions":258,"keywords":261,"overallStatus":48,"whyStopped":10,"lastUpdateSubmitDate":270,"lastUpdatePostDateStruct":271,"startDateStruct":274,"completionDateStruct":276,"leadSponsor":278,"locationsCount":279},{"fullName":5,"class":6},"McGill University","OTHER",[8,14,18,22],{"label":9,"type":10,"description":11,"interventionNames":12},"Consumers",null,"Individuals aged ≥18 years who have a risk factor for HCV acquisition or are attending a site that provides services to people with an HCV acquisition risk",[13],"Other: Preimplementation of HCV Point of care testing",{"label":15,"type":10,"description":16,"interventionNames":17},"Provider and manager","Participants must be currently employed at one of the research sites and involved in or supervising the delivery of HCV-related services.",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Decision-maker","Participants must hold a position in local, provincial, or national government, health authority or another organization that influences HCV testing and treatment policies and be able to provide insights into the strategic planning and funding for HCV care.",[13],{"label":23,"type":10,"description":24,"interventionNames":25},"Laboratory and quality assurance stakeholder","Participants must hold a role in laboratory services, quality assurance, or regulatory oversight of point-of-care testing at the provincial, national, or organizational level.",[13],[27],{"type":6,"name":28,"description":29,"armGroupLabels":30,"otherNames":10},"Preimplementation of HCV Point of care testing","Exploring the pre-implementation of HCV Point of care antibody and RNA tests",[9,19,23,15],[32],{"name":33,"affiliation":5,"role":34},"Guillaume Fontaine, RN, PhD","PRINCIPAL_INVESTIGATOR",[36,41],{"name":37,"role":38,"phone":39,"phoneExt":10,"email":40},"Meagan Mooney, RN, MA, BSc","CONTACT","514-994-9298","meagan.mooney@mail.mcgill.ca",{"name":42,"role":38,"phone":43,"phoneExt":10,"email":44},"Charlene Weight, MSc, BSc","5142340348","charlene.weight@mail.mcgill.ca",[46,67,73,85,96,110,121,131,142,156,170,184],{"facility":47,"status":48,"city":49,"state":50,"zip":51,"country":52,"countryCode":53,"cosmosGeoPoint":54,"geoPoint":59,"contacts":60},"Anonyme L'Unite D'Intervention","RECRUITING","Montreal","Quebec","H1N 1W2","Canada","CA",{"type":55,"coordinates":56},"Point",[57,58],-73.58781,45.50884,{"lat":58,"lon":57},[61,65],{"name":62,"role":38,"phone":63,"phoneExt":10,"email":64},"Renee Logan","416-535-8501","renee.logan@camh.ca",{"name":66,"role":34,"phone":10,"phoneExt":10,"email":10},"Mia PhD, NP-PHC, RN, PhD",{"facility":5,"status":68,"city":49,"state":50,"zip":69,"country":52,"countryCode":53,"cosmosGeoPoint":70,"geoPoint":72,"contacts":10},"ACTIVE_NOT_RECRUITING","H3S 1L8",{"type":55,"coordinates":71},[57,58],{"lat":58,"lon":57},{"facility":74,"status":75,"city":49,"state":50,"zip":10,"country":52,"countryCode":53,"cosmosGeoPoint":76,"geoPoint":78,"contacts":79},"Indigenous Health Centre of Tiohtià:ke","NOT_YET_RECRUITING",{"type":55,"coordinates":77},[57,58],{"lat":58,"lon":57},[80,84],{"name":81,"role":38,"phone":82,"phoneExt":10,"email":83},"Carrie Martin, BA, BSW, PhD","514-482-8557","carrie@ihct.ca",{"name":33,"role":34,"phone":10,"phoneExt":10,"email":10},{"facility":86,"status":48,"city":49,"state":50,"zip":10,"country":52,"countryCode":53,"cosmosGeoPoint":87,"geoPoint":89,"contacts":90},"L'Anonyme",{"type":55,"coordinates":88},[57,58],{"lat":58,"lon":57},[91,95],{"name":92,"role":38,"phone":93,"phoneExt":10,"email":94},"Nina Micaleff","514-842-1488","nmicaleff@anonyme.ca",{"name":33,"role":34,"phone":10,"phoneExt":10,"email":10},{"facility":97,"status":75,"city":98,"state":50,"zip":10,"country":52,"countryCode":53,"cosmosGeoPoint":99,"geoPoint":103,"contacts":104},"Centre de réadaptation en dépendance de Québec (CRDQ)","Québec",{"type":55,"coordinates":100},[101,102],-71.21454,46.81228,{"lat":102,"lon":101},[105,109],{"name":106,"role":38,"phone":107,"phoneExt":10,"email":108},"Ann-Sophie Allard, MD","418 663-5008","ann-sophie.allard.med@ssss.gouv.qc.ca",{"name":33,"role":34,"phone":10,"phoneExt":10,"email":10},{"facility":111,"status":75,"city":49,"state":10,"zip":10,"country":52,"countryCode":53,"cosmosGeoPoint":112,"geoPoint":114,"contacts":115},"Medicins du Monde",{"type":55,"coordinates":113},[57,58],{"lat":58,"lon":57},[116,120],{"name":117,"role":38,"phone":118,"phoneExt":10,"email":119},"Renee Boucher Beaulieu","514 281-8998","infirmiers.mtl@medecinsdumonde.ca",{"name":33,"role":34,"phone":10,"phoneExt":10,"email":10},{"facility":122,"status":75,"city":123,"state":10,"zip":10,"country":52,"countryCode":53,"cosmosGeoPoint":10,"geoPoint":10,"contacts":124},"Okanagan prison","Okanagan",[125,129],{"name":126,"role":38,"phone":127,"phoneExt":10,"email":128},"Amanda Slaunwhite, PhD","604 822 2772","amanda.slaunwhite@phsa.ca",{"name":130,"role":34,"phone":10,"phoneExt":10,"email":10},"Sofia Bartlett, PhD",{"facility":132,"status":75,"city":98,"state":10,"zip":10,"country":52,"countryCode":53,"cosmosGeoPoint":133,"geoPoint":135,"contacts":136},"SABSA Cooperative",{"type":55,"coordinates":134},[101,102],{"lat":102,"lon":101},[137,141],{"name":138,"role":38,"phone":139,"phoneExt":10,"email":140},"Marie-Christine Leclerc","418 914-9295","responsable.voletsdeservice@sabsa.ca",{"name":33,"role":34,"phone":10,"phoneExt":10,"email":10},{"facility":143,"status":75,"city":144,"state":10,"zip":10,"country":52,"countryCode":53,"cosmosGeoPoint":145,"geoPoint":149,"contacts":150},"Sioux Lookout First Nation Health Authority","Sioux Lookout",{"type":55,"coordinates":146},[147,148],-91.92158,50.09906,{"lat":148,"lon":147},[151,154],{"name":10,"role":38,"phone":152,"phoneExt":10,"email":153},"(807) 737-5182","privacy@slfnha.com",{"name":155,"role":34,"phone":10,"phoneExt":10,"email":10},"Mia Biondi, PhD, NP-PHC",{"facility":157,"status":75,"city":158,"state":10,"zip":10,"country":52,"countryCode":53,"cosmosGeoPoint":159,"geoPoint":163,"contacts":164},"Ontario - Provincial correction","Toronto",{"type":55,"coordinates":160},[161,162],-79.39864,43.70643,{"lat":162,"lon":161},[165,169],{"name":166,"role":38,"phone":167,"phoneExt":10,"email":168},"Lori Kiefer","647-302-9916","lori.kiefer@ontario.ca",{"name":155,"role":34,"phone":10,"phoneExt":10,"email":10},{"facility":171,"status":75,"city":172,"state":10,"zip":10,"country":52,"countryCode":53,"cosmosGeoPoint":173,"geoPoint":177,"contacts":178},"Rapid Access Addiction Clinic St Paul's Hospital","Vancouver",{"type":55,"coordinates":174},[175,176],-123.11934,49.24966,{"lat":176,"lon":175},[179,183],{"name":180,"role":38,"phone":181,"phoneExt":10,"email":182},"Julia MacIsaac, MD, MPH, ABIM, FRCPC","604-806-8867","drmacisaacmd@gmail.com",{"name":130,"role":34,"phone":10,"phoneExt":10,"email":10},{"facility":185,"status":75,"city":186,"state":10,"zip":10,"country":52,"countryCode":53,"cosmosGeoPoint":187,"geoPoint":191,"contacts":192},"Maamwesying North Shore Community Health Services","Wawa",{"type":55,"coordinates":188},[189,190],-84.77411,47.98877,{"lat":190,"lon":189},[193,197],{"name":194,"role":38,"phone":195,"phoneExt":10,"email":196},"Richard Sans Cartier, NP","705-844-2021","privacy@nmninoeyaa.ca",{"name":155,"role":34,"phone":10,"phoneExt":10,"email":10},{"type":34,"investigatorFullName":199,"investigatorTitle":200,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Guillaume Fontaine","Assistant Professor",[202,204,207,209,211,213,215,217,219,221,223,225,227,230,232,234,236,238,240],{"name":203,"class":6},"The University of New South Wales",{"name":205,"class":206},"Canadian Institutes of Health Research (CIHR)","OTHER_GOV",{"name":208,"class":6},"Jewish General Hospital",{"name":210,"class":6},"University of British Columbia",{"name":212,"class":206},"British Columbia Centre for Disease Control",{"name":214,"class":6},"University of Toronto",{"name":216,"class":6},"York University",{"name":218,"class":6},"Ottawa Hospital Research Institute",{"name":220,"class":6},"University of Ottawa",{"name":222,"class":6},"McGill University Health Centre\u002FResearch Institute of the McGill University Health Centre",{"name":224,"class":6},"Centre de Recherche du Centre Hospitalier de l'Université de Montréal",{"name":226,"class":6},"Lady Davis Institute",{"name":228,"class":229},"International Network on Health and Hepatitis in Substance Users","UNKNOWN",{"name":231,"class":206},"Public Health Agency of Canada (PHAC)",{"name":233,"class":229},"Canadian Association of People who Use Drugs",{"name":235,"class":229},"Action Hepatitis Canada",{"name":237,"class":229},"Canadian Liver Foundation",{"name":239,"class":229},"CATIE",{"name":241,"class":229},"Canadian Network on Hepatitis C","100600261","scaling-up-point-of-care-hepatitis-c-testing-and-treatment-in-canada-100600261",false,"NCT07095192","Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada","Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada: A Multilevel Implementation Science Study of Clinical Processes, Barriers, Facilitators and Implementation Strategies","SCALE POCT","Inclusion Criteria:\n\n* Individuals aged ≥18 years who have a risk factor for HCV acquisition or are attending a site that provides services to people with an HCV acquisition risk.\n* Service providers and managers who are currently employed at a site providing HCV-related services, involved in or supervising the delivery of HCV-related services.\n* Policymaker must hold a position in local, provincial, or national government or a health authority that influences HCV testing\u002Ftreatment policies and be able to provide insights into the strategic planning and funding for HCV care.\n* Laboratory and quality assurance stakeholders must hold a role in laboratory services, quality assurance, or regulatory oversight of point-of-care testing at the provincial, national, or organizational level.\n\nExclusion Criteria:\n\n* Younger than 18 years old","ALL","18 Years",{"count":253,"type":254},300,"ESTIMATED","1 Month","OBSERVATIONAL","The SCALE-POCT study is a national initiative designed to provide robust evidence for scaling up point-of-care hepatitis C testing for key populations. The study seeks to map current hepatitis C clinical processes, identify barriers and facilitators to implementation, and co-design practical tools and strategies in partnership with stakeholders.\n\nA major obstacle to hepatitis C elimination and increasing treatment uptake is the current multi-step diagnostic process, which leads to loss to follow-up and treatment delays, particularly among high-risk groups such as people who inject drugs. Point of-care hepatitis C antibody tests (results: 5-20 mins) and RNA tests (results: 60 mins), could enable single-visit diagnosis, reducing loss to follow-up. However, integrating these tests into key settings presents challenges. The overarching goal of this study is to generate evidence to inform the scale-up point-of-care hepatitis C testing and treatment in key settings in Canada. This study is observational in nature and does not involve the direct implementation of point-of-care hepatitis C testing. Instead, it aims to understand the contextual, procedural, and operational factors that would support its successful adoption and sustainability. By examining existing care models and engaging with key stakeholders, the study seeks to build a foundation for future implementation efforts. Specific objectives include:\n\n1. Map current hepatitis C care processes and explore how point-of-care testing could fit into these models;\n2. Identify barriers and facilitators to implementing point-of-care hepatitis C testing across settings and provinces;\n3. Co-design tools and strategies (such as training guides, standard procedures) to support point-of-care testing;\n4. Assess feasibility, acceptability, and costs of the co-designed tools and strategies.",[259,260],"HCV","HEPATITIS C VIRUS CHRONIC INFECTION",[259,262,263,264,265,266,267,268,269],"Hepatitis C Virus Chronic Infection","Rapid point-of-care testing","Implementation science","Knowledge translation","Marginalized populations","Infectious diseases","Barriers and facilitators","Implementation strategies","2025-07-23",{"date":272,"type":273},"2025-07-31","ACTUAL",{"date":275,"type":273},"2025-05-20",{"date":277,"type":254},"2028-09-20",{"name":5,"class":6},12]